Proceedings: Alkaline sucrose gradient sedimentation studies of DNA synthesized in methyl-azoxymethanol acetate treated HeLa cells.

Por Van den Berg, H. W.
Publicado em 1974

Proceedings: Synergism between the anti-tumour agent cis platinum (II) diamminedichloride and caffeine: toxicological and molecular studies.

Por van den Berg, H. W., Roberts, J. J.
Publicado em 1975

High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.

Por van den Berg, H. W., Martin, J., Lynch, M.
Publicado em 1990

Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.

Por Clarke, R., Van den Berg, H. W., Kennedy, D. G., Murphy, R. F.
Publicado em 1985

Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast ca...

Por Long, B., McKibben, B. M., Lynch, M., van den Berg, H. W.
Publicado em 1992

Proceedings: The kinetic response of HeLa cells to MAM acetate treatment.

Por Bedford, A. J., Knowles, J. D., Kenny, T. E., Van den Berg, H. W.
Publicado em 1974

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen...

Por van den Berg, H. W., Leahey, W. J., Lynch, M., Clarke, R., Nelson, J.
Publicado em 1987

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.

Por McDermott, B. J., Van den Berg, H. W., Martin, W. M., Murphy, R. F.
Publicado em 1983

Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormon...

Por van den Berg, H. W., Claffie, D., Boylan, M., McKillen, J., Lynch, M., McKibben, B.
Publicado em 1996

Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype.

Por van den Berg, H. W., Lynch, M., Martin, J., Nelson, J., Dickson, G. R., Crockard, A. D.
Publicado em 1989